scholarly journals Marine Organisms as a Rich Source of Biologically Active Peptides

2021 ◽  
Vol 8 ◽  
Author(s):  
Maria Wanna Figueiredo Sena Macedo ◽  
Nicolau Brito da Cunha ◽  
Juliana Araújo Carneiro ◽  
Rosiane Andrade da Costa ◽  
Sergio Amorim de Alencar ◽  
...  

Oceanic environments are one of the largest sources of bioactive molecules, due to the high degree of biodiversity and the innumerable ecological relationships established between macro and microorganisms found in the different ecosystems of these complex environments. Marine organisms are being studied increasingly because they are considered important producers of biologically active peptides. Peptides extracted from marine sources have different functions and structures, when compared to peptides isolated from terrestrial sources, considering the different adaptive pressures undergone by these organisms throughout the evolutionary process. Most bioactive compounds isolated from marine environments are obtained from symbiont microorganisms. Of these microorganisms, bacteria are an important source of bioactive peptides, isolated by metagenomic studies from complex gene networks expressed under marine conditions. Several peptides have been shown to have biotechnological properties such as antimicrobial, antitumor, antihypertensive, anticoagulant, anti-fouling, and antioxidant activity and can be used in the pharmaceutical and food industries. This review article aims to provide an overview of peptides of biotechnological importance, isolated from different phyla of marine organisms, examining the relationship between structure and function of some of these peptides, as well as the ways of extracting, purifying and prospecting new peptides by traditional methods of isolation or sequence analysis in databases. It also intends to list the peptides that are already being produced and used by the industry, in its various branches, and their current state in the market and in clinical tests.

2003 ◽  
Vol 31 (3) ◽  
pp. 723-727 ◽  
Author(s):  
A.J. Turner

Neprilysin [or neutral endopeptidase (NEP)] and angiotensin-converting enzyme (ACE) are zinc metallopeptidases involved in the extracellular metabolism of biologically active peptides. Recent genomic advances have led to the identification of novel homologues of each of these ectoenzymes and new physiological and pathological roles are emerging for them. The structures of each of these peptidases have recently been solved providing insight into their distinct catalytic sites. In addition to its originally identified role in neuropeptide metabolism in the nervous system, NEP is implicated in regulation of the cardiovascular system and is protective in prostate and certain other cancers. Hence the cellular concentration of NEP is critical to tissue homoeostasis. Most recently, NEP has been shown to exert neuroprotective actions, principally through its ability to catabolize the neurotoxic Alzheimer's amyloid peptide. The only known homologue of ACE, termed ACE2, is critical to cardiovascular function, but its physiological substrates and precise metabolic roles remain to be elucidated. Other members of these growing metallopeptidase families await further characterization and possible exploitation as therapeutic targets.


2010 ◽  
Vol 16 (30) ◽  
pp. 3390-3400 ◽  
Author(s):  
Abba J. Kastin ◽  
Weihong Pan

2008 ◽  
Vol 12 (4) ◽  
pp. 115-123 ◽  
Author(s):  
Masahiko Mori ◽  
Shinichiro Sumitomo ◽  
Prashanta Shrestha ◽  
Shiro Tanaka ◽  
Yoshiaki Takai ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document